Cargando…

Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4

Here, we developed a model system to evaluate the metabolic effects of oncogene(s) on the host microenvironment. A matched set of “normal” and oncogenically transformed epithelial cell lines were co-cultured with human fibroblasts, to determine the “bystander” effects of oncogenes on stromal cells....

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Outschoorn, Ubaldo E, Curry, Joseph M, Ko, Ying-Hui, Lin, Zhao, Tuluc, Madalina, Cognetti, David, Birbe, Ruth C, Pribitkin, Edmund, Bombonati, Alessandro, Pestell, Richard G, Howell, Anthony, Sotgia, Federica, Lisanti, Michael P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865048/ https://www.ncbi.nlm.nih.gov/pubmed/23860378 http://dx.doi.org/10.4161/cc.25510

Ejemplares similares

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment
por: Sotgia, Federica, et al.
Publicado: (2011)

Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015)

Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer
por: Bisetto, Sara, et al.
Publicado: (2018)

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
por: Johnson, Jennifer M., et al.
Publicado: (2017)

Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production
por: Capparelli, Claudia, et al.
Publicado: (2012)

Cancer stem cell metabolism
por: Peiris-Pagès, Maria, et al.
Publicado: (2016)

A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis
por: Ozsvari, Bela, et al.
Publicado: (2017)

Mitochondrial Fission Induces Glycolytic Reprogramming in Cancer-Associated Myofibroblasts, Driving Stromal Lactate Production, and Early Tumor Growth
por: Guido, Carmela, et al.
Publicado: (2012)

Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017)

Metabolic remodeling of the tumor microenvironment: Migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth
por: Carito, Valentina, et al.
Publicado: (2012)

CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth
por: Capparelli, Claudia, et al.
Publicado: (2012)

CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis
por: Capparelli, Claudia, et al.
Publicado: (2012)

Two-compartment tumor metabolism: Autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells
por: Salem, Ahmed F., et al.
Publicado: (2012)

Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?
por: Sotgia, Federica, et al.
Publicado: (2011)

Genetic Induction of the Warburg Effect Inhibits Tumor Growth
por: Sotgia, Federica, et al.
Publicado: (2012)

Cancer Metabolism: New Validated Targets for Drug Discovery
por: Sotgia, Federica, et al.
Publicado: (2013)

The reverse warburg effect in osteosarcoma
por: Sotgia, Federica, et al.
Publicado: (2014)

Thyroid Cancer Metabolism: A Review
por: Gill, Kurren S, et al.
Publicado: (2016)

Ras oncogene mutations and survival in patients with lung cancer
por: Ferretti, G, et al.
Publicado: (2006)

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
por: Lamb, Rebecca, et al.
Publicado: (2015)

Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
por: Lamb, Rebecca, et al.
Publicado: (2015)

Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma
por: Kroopnick, Jeffrey M., et al.
Publicado: (2021)

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
por: Lamb, Rebecca, et al.
Publicado: (2015)

Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
por: Pavlides, Stephanos, et al.
Publicado: (2010)

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
por: Lamb, Rebecca, et al.
Publicado: (2014)

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity
por: Bonuccelli, Gloria, et al.
Publicado: (2016)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
por: Lee, Haksoo, et al.
Publicado: (2022)

Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
por: Fiorillo, Marco, et al.
Publicado: (2016)

Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers
por: Domingo-Vidal, Marina, et al.
Publicado: (2022)

Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
por: Curry, Joseph M., et al.
Publicado: (2018)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Carbonic anhydrase 9 (CA9) and redox signaling in cancer-associated fibroblasts: Therapeutic implications
por: Chadwick, Amy L, et al.
Publicado: (2013)

4D Genome Rewiring during Oncogene-Induced and Replicative Senescence
por: Sati, Satish, et al.
Publicado: (2020)

Exploiting signaling rewiring in cancer cells with co‐existing oncogenic drivers
por: Chiarle, Roberto, et al.
Publicado: (2023)

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
por: Fiorillo, Marco, et al.
Publicado: (2016)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1bemm3rg3el3jcllri27npkgu0